ASMB
Assembly Biosciences, Inc.Company with tickers: ASMB
CIK
1426800
CUSIP
045396207
Shares Outstanding
19,817,250
Website
https://www.assemblybio.com
13F Activity (30d)
35 filings
35 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $35,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $19,583,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Research & Development | $14,900,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Operating Income | $-11,370,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| Net Income | $-9,079,000 | USD | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Basic) | $-0.54 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |
| EPS (Diluted) | $-0.54 | USD/shares | 2026-03-31 | 10-Q | 2026-05-07 |